CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Sponsor
Russian Society of Colorectal Surgeons (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06119867
Collaborator
(none)
430
1
2
25
17.2

Study Details

Study Description

Brief Summary

In general, the European pathological examination method primarily relies on pathologists and does not require the involvement of surgeons. The Japanese pathological evaluation approach, on the other hand, involves the intervention of surgeons, particularly in the extraction of lymph nodes from fresh specimens and the assessment of specimen quality. Given that the Japanese pathological assessment method lacks systematic evaluation and there is currently no literature clearly demonstrating its diagnostic accuracy, the main objective of this study is to verify whether the diagnostic accuracy of the Japanese pathological investigation method is inferior to that of the European pathological evaluation method.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Japanese pathological investigation
  • Procedure: European pathological investigation
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
430 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Comparison Between the European and Japanese Pathological Investigation for Colon Cancer (SPACE)
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Oct 12, 2025
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Japanese pathological investigation method group

The surgeon will be involved into the Japanese pathological investigation method. The surgeon will perform the intraoperative markings and the postoperative lymph node harvest, after which the specimen will be assessed by the pathologist.

Procedure: Japanese pathological investigation
Japanese pathological investigation

Active Comparator: European pathological investigation method group

After receiving the resected specimen, the entire process will be independently managed by the pathologist.

Procedure: European pathological investigation
The European pathology evaluation method involves the analysis of fresh and intact specimens. Pathologists carefully inspect the entire specimen's appearance and assess the surgical resection plane and capture complete photographs for documentation purposes before further sectioning the specimen. During specimen processing, the CRM is initially marked with ink or other markers. After fixation, macroscopic data are recorded, and the entire length of the intestine is cut into cross-sections at intervals of 3-4 millimeters. These sections are then undergoing subsequent systematic pathological examination. However, the surgeon will be involved in the Japanese pathological investigation method. Intraoperative markings will be made 10 cm bilaterally from the primary tumor area. The resected colon will be incised at 1 cm intervals, after which the pericolic lymph nodes will be harvested. Each single retrieved lymph node will be packed up independently and will be examined by the pathologist.

Outcome Measures

Primary Outcome Measures

  1. Comparision of the incidence of stage III colon cancer between European and Japanese pathological investigation methods. [up to 24 months]

    indentification of the rate of postive lymph nodes

Secondary Outcome Measures

  1. The role of immunohistochemical examination in the Node (N) stage determination [up to 24 months]

    indentification of the rate of postive lymph nodes using immunohistochemical examination

  2. Comparison of the lymph node ratio (LNR) between the European and Japanese pathological approaches [up to 24 months]

    LNR=Postivie lymph node/ Total retrived lymph node

  3. Comparison of the pT Stage between the European and Japanese pathological approaches [up to 24 months]

    indentification of the rate of the pathological T stages

  4. Comparison of the resection margin (proximal, distal, circular) between the European and Japanese pathological approaches [up to 24 months]

    indentification of the rate of the postive proximal, distal or circular resection margin

  5. Comparison of the tumor budding between the European and Japanese pathological approaches [up to 24 months]

    indentification of the rate of tumor budding

  6. Comparison of the tumor-infiltrating lymphocytes (TIL) count between the European and Japanese pathological approaches [up to 24 months]

    indentification of the rate of the tumor-infiltrating lymphocytes (TIL) count

  7. Comparison of the extracapsular invasion between the European and Japanese pathological approaches [up to 24 months]

    indentification of the rate of the extracapsular invasion

  8. Comparison of the extramural invasion (venous, lymphatic, perineural) between the European and Japanese pathological approaches [up to 24 months]

    indentification of the rate of the venous, lymphatic or perineural extramural invasion

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients diagnosed with colon cancer who underwent colectomy;

  • Patients with pathological confirmed adenocarcinoma;

  • Patients agreed to participate in the study.

Exclusion Criteria:
  • Patients suffered from rectal cancer;

  • Patients diagnosed with colon cancer but did not undergo colectomy;

  • Patients refused participation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinic of coloproctology and minimally invasive surgery Moscow Russian Federation

Sponsors and Collaborators

  • Russian Society of Colorectal Surgeons

Investigators

  • Principal Investigator: Vladimir Balaban, Sechenov University
  • Study Director: Petr Tsarkov, Sechenov University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vladimir Balaban, Principal Investigator, Russian Society of Colorectal Surgeons
ClinicalTrials.gov Identifier:
NCT06119867
Other Study ID Numbers:
  • 0004
First Posted:
Nov 7, 2023
Last Update Posted:
Nov 7, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 7, 2023